🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to compare the efficacy and safety of first-line ico...
Status
Unknown
Location
Chinese People's Liberation Army (PLA) General Hospital
Start Date
2012-08
Trial ID
NCT01665417
Treatments Being Tested
This phase II randomised, double blind, placebo controlled, multicentre tri...
Status
Unknown
Location
Hunan Province Tumor Hospital
Start Date
2012-09
Trial ID
NCT01707329
Treatments Being Tested
Epidermal growth factor receptor (EGFR) mutations occur in up to 50% of Asi...
Status
Unknown
Location
Multiple Locations
Start Date
2019-07-01
Trial ID
NCT03983811
Treatments Being Tested
Phase II Study of Icotinib Hydrochloride in Treating Patients With Recurren...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2013-10
Trial ID
NCT01973725
Treatments Being Tested
EGFR-TKI is good for the patients with EGFR-mutant non-small cell lung canc...
Status
Completed
Location
Guangdong General Hospital
Start Date
2012-10-14
Trial ID
NCT01724801
Treatments Being Tested
This is a Phase II, single-Arm, prospective study of neoadjuvant Icotinib w...
Status
Recruiting
Location
BeijingCancerH
Start Date
2021-10-25
Trial ID
NCT05104788
Treatments Being Tested
EGFR-tyrosine kinase inhibitor(TKI)- ie, erlotinib, gefitinib, icotinib,has...
Status
Unknown
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT03151161
Treatments Being Tested
This single-arm, open, multicenter clinical study is going to evaluate the ...
Status
Unknown
Location
Department of Pulmonary Medical Oncology, Tianjin Medical University Cancer Hospital
Start Date
2019-07-01
Trial ID
NCT03992885
Treatments Being Tested
This is a randomized ,opened, prospective controlled trial of clinical effe...
Status
Unknown
Location
PLA General Hospital
Start Date
2014-10
Trial ID
NCT02283424
Treatments Being Tested
The purpose of this study is to evaluate the overall response rate and dise...
Status
Unknown
Location
Zhejiang cancer hospital
Start Date
2013-04
Trial ID
NCT01843647
Treatments Being Tested